Pramila

Environmental sensors using bioelectronics have the potential to be the most commercially adopted category due to their broad applications, lower regulatory barriers, and scalability. With increasing global concerns about pollution, climate change, and water quality, bio-based sensors that detect toxins, pathogens, or environmental changes will be in high demand. Unlike implantable medical devices, which face strict regulations and high costs, environmental sensors can be deployed faster and at scale, making them attractive for governments, industries, and even consumers. Advances in microbial fuel cells, bio-hybrid air quality monitors, and water contamination detectors make this a rapidly growing field, and large-scale adoption could happen sooner than medical bioelectronics due to public health and environmental priorities.

Till now FDA has not approved repurposing existing drug used for neurodegenrative diseases for Traumatic brain injuries. There are few drugs such as buntanetap, edaravone which has shown efficiency in brain injury treatment but they have not been fully tested yet. And these drugs need to be accurate enough to be used in sensible brain traumatic injury so it will take a long time for any reusable drug to be approved.

While initially I was also not quite optmistic on its possibility and based on other forecasters forecast, I am reducing the chance of probability as well.